NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.

Breast Cancer Res · 2019 · PMC6923956 · PMID 31856858

Europe PMC DOI

hedged sentence

0.1040

closest p · 2.1× alpha

0.1040

boldest claim

The sentences

did not reach statistical significanceP = 0.104not close (p > 0.1)

However, the difference in NEDD4 expression between hormone receptor positive, Her2-enriched, and triple negative tumors did not reach statistical significance (Table 1 , χ 2 = 6.161, P = 0.104).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.